XF, L., W, M., G, H., FX, C., W, X., AA, A., . . . Bast, R. C. J. (2011). The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells. JNCI: Journal of the National Cancer Institute, 103(18), 1403. https://doi.org/10.1093/jnci/djr280
Chicago Style (17th ed.) CitationXF, Le, et al. "The Role of P27(Kip1) in Dasatinib-enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells." JNCI: Journal of the National Cancer Institute 103, no. 18 (2011): 1403. https://doi.org/10.1093/jnci/djr280.
MLA (9th ed.) CitationXF, Le, et al. "The Role of P27(Kip1) in Dasatinib-enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells." JNCI: Journal of the National Cancer Institute, vol. 103, no. 18, 2011, p. 1403, https://doi.org/10.1093/jnci/djr280.